Monitoring interactions inside cells by advanced spectroscopies: Overview of 
copper transporters and cisplatin.

Lasorsa, A.; Natile, G.; Rosato, A.; Tadini-Buoninsegni , F.; Arnesano , F.

doi:10.1174/0919867314666171110141311

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2558401_5

DetailsSummary

Released

Journal Article

Monitoring interactions inside cells by advanced spectroscopies: Overview of copper transporters and cisplatin.

MPS-Authors

/persons/resource/persons217504

Lasorsa, A.
Research Group of Protein Structure Determination using NMR, MPI for Biophysical Chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Lasorsa, A., Natile, G., Rosato, A., Tadini-Buoninsegni, F., & Arnesano, F. (2018). Monitoring interactions inside cells by advanced spectroscopies: Overview of copper transporters and cisplatin. Current Medicinal Chemistry, 25(4), 462-477. doi:10.1174/0919867314666171110141311.

Cite as: https://hdl.handle.net/21.11116/0000-0000-D04D-F

Abstract

Background: Resistance, either at the onset of the treatment or developed after an initial positive response, is a major limitation of antitumor therapy. In the case of platinum-based drugs, copper transporters have been found to interfere with drug trafficking by facilitating the import or favoring the platinum export and inactivation. Methods: The use of powerful spectroscopic, spectrometric and computational methods has allowed a deep structural insight into the mode of interaction of platinum drugs with the metal-binding domains of the transporter proteins. Results: This review article focuses on the mode in which platinum drugs can compete with copper ion for binding to transport proteins and consequent structural and biological effects. Three types of transporters are discussed in detail: copper transporter 1 (Ctrl), the major responsible for Cu+ uptake; antioxidant-1 copper chaperone (Atoxl), responsible for copper transfer within the cytoplasm; and copper ATPases (ATP7A/B), responsible for copper export into specific subcellular compartments and outside the cell. Conclusion: The body of knowledge summarized in this review can help in shaping current chemotherapy to optimize the efficacy of platinum drugs (particularly in relation to resistance) and to mitigate adverse effects on copper metabolism.